1. Inhibition of Cell Survival by Curcumin Is Associated with Downregulation of Cell Division Cycle 20 (Cdc20) in Pancreatic Cancer Cells.
    Yu Zhang et al, 2017, Nutrients CrossRef
  2. Compound 331 selectively induces glioma cell death by upregulating miR-494 and downregulating CDC20.
    Lei Zhang et al, 2015, Sci Rep CrossRef
  3. Targeting Cdc20 as a novel cancer therapeutic strategy
    Lixia Wang et al, 2015, Pharmacology & Therapeutics CrossRef
  4. Cell division cycle 20 promotes cell proliferation and invasion and inhibits apoptosis in osteosarcoma cells
    Guanning Shang et al, 2017, Cell Cycle CrossRef
  5. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis
    Lin Li et al, 2017 CrossRef
  6. Silencing of CDC20 suppresses metastatic castration-resistant prostate cancer growth and enhances chemosensitivity to docetaxel.
    Ke Li et al, 2016, Int J Oncol CrossRef
  7. Cdc20: At the Crossroads between Chromosome Segregation and Mitotic Exit
    Maria Kapanidou et al, 2017, Trends in Biochemical Sciences CrossRef
  8. Aneuploidy: Cancer strength or vulnerability?
    Giorgia Simonetti et al, 2018, Int. J. Cancer CrossRef
  9. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma
    Peng-Fei Chen et al, 2018, J Cell Biochem CrossRef
  10. Diosgenin exerts its tumor suppressive function via inhibition of Cdc20 in osteosarcoma cells.
    Cheng Long et al, 2019, Cell Cycle CrossRef
  11. Identification of Potential Key Genes for Hepatitis B Virus-Associated Hepatocellular Carcinoma by Bioinformatics Analysis
    Zide Chen et al, 2019, Journal of Computational Biology CrossRef
  12. Transcriptome Analysis Revealed a Highly Connected Gene Module Associated With Cirrhosis to Hepatocellular Carcinoma Development
    Shan Shan et al, 2019, Front. Genet. CrossRef
  13. Identification of core genes and potential molecular mechanisms in breast cancer using bioinformatics analysis
    Fei Liu et al, 2019, Pathology - Research and Practice CrossRef
  14. APC/CCDC20 and APC/C play pivotal roles in the process of embryonic development in Artemia sinica
    Mengchen Zhang et al, 2016, Sci Rep CrossRef
  15. Growth Regulation in Hepatobiliary Cancer: Regulators of the Cell Division Cycle
    Arthur Zimmermann, 2016 CrossRef
  16. The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma
    Anke Maes et al, 2019, Br J Cancer CrossRef
  17. Genetically engineered flavonol enriched tomato fruit modulates chondrogenesis to increase bone length in growing animals
    Dharmendra Choudhary et al, 2016, Sci Rep CrossRef
  18. Defective mitosis-linked DNA damage response and chromosomal instability in liver cancer
    Maryam Tahmasebi Birgani et al, 2019, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  19. A comprehensive analysis of CDC20 overexpression in common malignant tumors from multiple organs: its correlation with tumor grade and stage.
    Mariana F Gayyed et al, 2016, Tumour Biol CrossRef
  20. CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy.
    Lutfi H Alfarsi et al, 2019, Breast Cancer Res Treat CrossRef
  21. Growth Regulation in Hepatobiliary Cancer: Regulators of the Cell Division Cycle
    Arthur Zimmermann, 2017 CrossRef
  22. Identification of personalized dysregulated pathways in hepatocellular carcinoma
    Hong Li et al, 2017, Pathology - Research and Practice CrossRef
  23. A regulation probability model-based meta-analysis of multiple transcriptomics data sets for cancer biomarker identification.
    Xin-Ping Xie et al, 2017, BMC Bioinformatics CrossRef
  24. SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG
    Peng Tan et al, 2019, Cell Death Dis CrossRef
  25. Based on Integrated Bioinformatics Analysis Identification of Biomarkers in Hepatocellular Carcinoma Patients from Different Regions
    Linxin Teng et al, 2019, BioMed Research International CrossRef
  26. The Identification of Potential Therapeutic Targets for Cutaneous Squamous Cell Carcinoma
    Angela McHugh et al, 2019, Journal of Investigative Dermatology CrossRef
  27. Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4
    Chao Ye et al, 2019, Cell Oncol. CrossRef
  28. The Anaphase Promoting Complex/Cyclosome (APC/C): A Versatile E3 Ubiquitin Ligase
    Natalie L. Curtis et al, 2019 CrossRef
  29. Identification of hub genes and analysis of prognostic values in hepatocellular carcinoma by bioinformatics analysis
    Liangfei Xu et al, 2020, The American Journal of the Medical Sciences CrossRef
  30. Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO Data.
    Yingkun Xu et al, 2020, Biomed Res Int CrossRef
  31. Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons
    Jaitip Tipanee et al, 2020, Molecular Therapy - Nucleic Acids CrossRef
  32. Identification of 13 Key Genes Correlated With Progression and Prognosis in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis
    Yang Gu et al, 2020, Front. Genet. CrossRef
  33. Deregulation of Chromosome Segregation and Cancer
    Natalie L. Curtis et al, 2020, Annu. Rev. Cancer Biol. CrossRef
  34. Transcriptome analysis revealed key prognostic genes and microRNAs in hepatocellular carcinoma
    Xi Ma et al, 2020 CrossRef
  35. inFRank: a ranking-based identification of influential genes in biological networks
    Xiuliang Cui et al, 2017, Oncotarget CrossRef
  36. Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
    Xu Liping et al, 2020, BioMed Research International CrossRef
  37. Integrative module analysis of HCC gene expression landscapes
    Hongshi Li et al, 2020, Exp Ther Med CrossRef
  38. Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV‑associated hepatocellular carcinoma
    Lijie Zhang et al, 2020, Exp Ther Med CrossRef
  39. CDC20 associated with cancer metastasis and novel mushroom‑derived CDC20 inhibitors with antimetastatic activity.
    Shujie Cheng et al, 2019, Int J Oncol CrossRef
  40. CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt/β‑catenin signaling pathway
    Zhaowei Chu et al, 2019, Int J Oncol CrossRef
  41. A prognostic prediction system for hepatocellular carcinoma based on gene co‑expression network
    Lianyue Guan et al, 2019, Exp Ther Med CrossRef
  42. Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis
    Qifan Zhang et al, 2019, Mol Med Report CrossRef
  43. Identification of candidate genes associated with the pathogenesis of small cell lung cancer via integrated bioinformatics analysis.
    Yi Liao et al, 2019, Oncol Lett CrossRef
  44. Bioinformatics analysis of gene expression profile of serous ovarian carcinomas to screen key genes and pathways
    Hongjun Fei et al, 2020, J Ovarian Res CrossRef
  45. Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis
    Ziqi Meng et al, 2020, J Int Med Res CrossRef
  46. A twenty gene-based gene set variation score reflects the pathological progression from cirrhosis to hepatocellular carcinoma
    Yan Lin et al, 2019, Aging CrossRef
  47. The role of Anaphase Promoting Complex activation, inhibition and substrates in cancer development and progression.
    Cordell VanGenderen et al, 2020, Aging (Albany NY) CrossRef
  48. Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression
    Zuo Fei et al, 2020, Human Cell CrossRef
  49. Integrated analysis identifies a long non-coding RNAs-messenger RNAs signature for prediction of prognosis in hepatitis B virus-hepatocellular carcinoma patients
    Zhenzi Bai et al, 2020 CrossRef
  50. Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma
    Laner Shi et al, 2020, J Clin Pathol CrossRef
  51. APCCDC20-mediated degradation of PHD3 stabilizes HIF-1a and promotes tumorigenesis in hepatocellular carcinoma.
    Min Shi et al, 2021, Cancer Lett CrossRef
  52. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma
    Xia Chen et al, 2020, BioMed Research International CrossRef
  53. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Yuqin Tang et al, 2020, Biomed Res Int CrossRef
  54. Identification of hub genes and biological pathways in hepatocellular carcinoma by integrated bioinformatics analysis.
    Qian Zhao et al, 2021, PeerJ CrossRef
  55. Gene networks and transcriptional regulators associated with liver cancer development and progression
    Tatiana Meier et al, 2021, BMC Med Genomics CrossRef
  56. A gene module identification algorithm and its applications to identify gene modules and key genes of hepatocellular carcinoma
    Yan Zhang et al, 2021, Sci Rep CrossRef
  57. Identification of a five-gene signature in association with overall survival for hepatocellular carcinoma
    Lei Yang et al, 2021 CrossRef
  58. Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers.
    Maya S Krishnan et al, 2021, Hepatology CrossRef
  59. Extraction of Genes Associated with Liver Cancer Using Machine Learning
    Koshiro Sekine et al, 2020 CrossRef
  60. Application of Molecular Nanoprobes in the Analysis of Differentially Expressed Genes and Prognostic Models of Primary Hepatocellular Carcinoma
    Shuang Luo et al, 2021, j biomed nanotechnol CrossRef
  61. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis
    Junwei Liu et al, 2021, BioMed Research International CrossRef
  62. Identification of CDC20 as a Novel Biomarker in Diagnosis and Treatment of Wilms Tumor.
    Qinlin Shi et al, 2021, Front Pediatr CrossRef
  63. Low expression of KIF20A suppresses cell proliferation, promotes chemosensitivity and is associated with better prognosis in HCC
    Chuanxing Wu et al, 2021, Aging CrossRef
  64. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
    Chen Xiong et al, 2021, Invest New Drugs CrossRef
  65. Identification of 5 Hub Genes Related to the Early Diagnosis, Tumour Stage, and Poor Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis
    Rui Qiang et al, 2021, Computational and Mathematical Methods in Medicine CrossRef
  66. CCNB1 promotes the development of hepatocellular carcinoma by mediating DNA replication in the cell cycle
    Min-Hua Rong et al, 2021, Exp Biol Med (Maywood) CrossRef
  67. The effect of key DNA methylation in different regions on gene expression in hepatocellular carcinoma
    Yu-Xian Liu et al, 2021, Mol. Omics CrossRef
  68. CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
    Zhiqiang Yang et al, 2021, Int J Gen Med CrossRef
  69. Identification of the critical genes and miRNAs in hepatocellular carcinoma by integrated bioinformatics analysis
    Jun Wang et al, 2022, Med Oncol CrossRef
  70. Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosis
    Jiali Meng et al, 2022, Cancer Cell Int CrossRef
  71. Identification of potential biomarkers in hepatocellular carcinoma: A network-based approach
    Mehrdad Ameri et al, 2022, Informatics in Medicine Unlocked CrossRef
  72. Identification and Validation of Hub Genes Predicting Prognosis of Hepatocellular Carcinoma
    Ziyan Chen et al, 2021, Dig Surg CrossRef
  73. Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma
    Zhong-liu Wei et al, 2022, BMC Gastroenterol CrossRef
  74. Immune-related lincRNA pairs predict prognosis and therapeutic response in hepatocellular carcinoma
    Yingna Zhang et al, 2022, Sci Rep CrossRef
  75. CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
    Samantha Bruno et al, 2022, J Exp Clin Cancer Res CrossRef
  76. REC8 inhibits proliferation, migration and invasion of breast cancer cells by targeting CDC20.
    Shaodan He et al, 2022, Mol Med Rep CrossRef
  77. Computational Characterizing Necroptosis Reveals Implications for Immune Infiltration and Immunotherapy of Hepatocellular Carcinoma
    Jun Zhu et al, 2022, Front. Oncol. CrossRef
  78. Impaired Cdc20 signaling promotes senescence in normal cells and apoptosis in non-small cell lung cancer cells.
    Daniela Volonte et al, 2022, J Biol Chem CrossRef
  79. Cell-cycle and apoptosis related and proteomics-based signaling pathways of human hepatoma Huh-7 cells treated by three currently used multi-RTK inhibitors
    Xuejiao Ren et al, 2022, Front. Pharmacol. CrossRef
  80. Identification of BRIP1, NSMCE2, ANAPC7, RAD18 and TTL from chromosome segregation gene set associated with hepatocellular carcinoma
    Ceren Sucularli, 2022, Cancer Genetics CrossRef
  81. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis
    Yu Qiao et al, 2022, CBM CrossRef
  82. Construction of novel lncRNA-miRNA-mRNA ceRNA networks associated with prognosis of hepatitis C virus related hepatocellular carcinoma
    Lishi Shao et al, 2022, Heliyon CrossRef
  83. Targeting Cdc20 for cancer therapy.
    Seung Min Jeong et al, 2022, Biochim Biophys Acta Rev Cancer CrossRef
  84. Identification of Differentially Expressed Genes Associated with the Prognosis and Diagnosis of Hepatocellular Carcinoma by Integrated Bioinformatics Analysis
    Mohib Ullah Kakar et al, 2022, BioMed Research International CrossRef
  85. Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma
    Srinivas Reddy Pallerla et al, 2022, BMC Med Genomics CrossRef
  86. Screening of Hub Genes in Hepatocellular Carcinoma Based on Network Analysis and Machine Learning
    Yu Zhang et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
  87. Differentially Expressed Cell Cycle Genes and STAT1/3-Driven Multiple Cancer Entanglement in Psoriasis, Coupled with Other Comorbidities
    Subhashini Dorai et al, 2022, Cells CrossRef
  88. GENETIC DEVIATION ASSOCIATED WITH PHOTODYNAMIC THERAPY IN HELA CELL
    Asiye GOK YURTTAŞ et al, 2023, Photodiagnosis and Photodynamic Therapy CrossRef
  89. p53 directly downregulates the expression of CDC20 to exert anti-tumor activity in mantle cell lymphoma
    Yingtong Chen et al, 2023, Exp Hematol Oncol CrossRef
  90. Differentially expressed discriminative genes and significant meta-hub genes based key genes identification for hepatocellular carcinoma using statistical machine learning
    Md. Al Mehedi Hasan et al, 2023, Sci Rep CrossRef
  91. The structural flexibility of MAD1 facilitates the assembly of the Mitotic Checkpoint Complex
    Chu Chen et al, 2023, Nat Commun CrossRef
  92. p53 Directly Downregulates the Expression of CDC20 to Exert Anti-Tumor Activity in Mantle Cell Lymphoma
    Yingtong Chen et al, 2022, SSRN Journal CrossRef
  93. High Expression of Ten Eleven Translocation 1 Is Associated with Poor Prognosis in Hepatocellular Carcinoma
    Haopeng Wen et al, 2023, Mediators of Inflammation CrossRef
  94. Exploring the pathogenesis of colorectal carcinoma complicated with hepatocellular carcinoma via microarray data analysis
    Tianqi Gao et al, 2023, Front. Pharmacol. CrossRef
  95. Development and validation of a ubiquitin–proteasome system gene signature for prognostic prediction and immune microenvironment evaluation in hepatocellular carcinoma
    Zhi-yang Liu et al, 2023, J Cancer Res Clin Oncol CrossRef
  96. Anticancer Potential of Biologically Active Diosgenin and its Derivatives: An Update
    Sadhan Mondal, 2024, CTM CrossRef
  97. Anti-tumor target screening of sea cucumber saponin Frondoside A: a bioinformatics and molecular docking analysis
    Guangchun Liu et al, 2023, Front. Oncol. CrossRef
  98. G6PD and machine learning algorithms as prognostic and diagnostic indicators of liver hepatocellular carcinoma
    Fei Li et al, 2024, BMC Cancer CrossRef
  99. Comprehensive analysis of the potential pathogenesis of COVID-19 infection and liver cancer
    Yao Rong et al, 2024, World J Gastrointest Oncol CrossRef
  100. Deciphering the latent biomarkers in HBV and HDV- associated HepatoCellular carcinoma – An integrated bioinformatics analysis
    Nandan Dixit et al, 2024, Human Gene CrossRef
  101. Early-stage biomarkers identification by integrated genomic analysis in Hepatocellular carcinoma
    Suryaa Manoharan et al, 2024, Medicine in Omics CrossRef
  102. Antitumor Effect of Apcin on Endometrial Carcinoma via p21-Mediated Cell Cycle Arrest and Apoptosis
    Ke Ni et al, 2024, CURR MED SCI CrossRef
  103. Prognostic and Therapeutic Implications of Cell Division Cycle 20 Homolog in Breast Cancer
    Samia S. Messeha et al, 2024, Cancers CrossRef
  104. The potential role of CDC20 in tumorigenesis, cancer progression and therapy: A narrative review
    Feng Xian et al, 2023 CrossRef
  105. Integrated GMPS and RAMP3 as a signature to predict prognosis and immune heterogeneity in hepatocellular carcinoma
    Zhuoyan Chen et al, 2024, Gene CrossRef
  106. Forkhead box C1 promotes the pathology of osteoarthritis in subchondral bone osteoblasts via the Piezo1/YAP axis
    Zhengyuan Li et al, 2024, Cellular Signalling CrossRef
  107. Klrb1 Loss Promotes Chronic Hepatic Inflammation and Metabolic Dysregulation
    Shuqi Yang et al, 2024, Genes CrossRef
  108. Predictive Prognostic Model for Hepatocellular Carcinoma Based on Seven Genes Participating in Arachidonic Acid Metabolism
    Xinyu Gu et al, 2024, Cancer Medicine CrossRef
  109. CDC20 and CCNB1 Overexpression as Prognostic Markers in Bladder Cancer
    Hatice Sevim Nalkiran et al, 2024, Diagnostics CrossRef